NZ586037A - Sm-protein based secretion engineering - Google Patents

Sm-protein based secretion engineering

Info

Publication number
NZ586037A
NZ586037A NZ586037A NZ58603708A NZ586037A NZ 586037 A NZ586037 A NZ 586037A NZ 586037 A NZ586037 A NZ 586037A NZ 58603708 A NZ58603708 A NZ 58603708A NZ 586037 A NZ586037 A NZ 586037A
Authority
NZ
New Zealand
Prior art keywords
protein
interest
protein based
based secretion
proteins
Prior art date
Application number
NZ586037A
Other languages
English (en)
Inventor
Hitto Kaufmann
Eric Becker
Lore Florin
Martin Fussenegger
Ren-Wang Peng
Joey M Studts
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NZ586037A publication Critical patent/NZ586037A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ586037A 2007-12-20 2008-12-19 Sm-protein based secretion engineering NZ586037A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07150254 2007-12-20
EP08152829 2008-03-17
PCT/EP2008/010882 WO2009080299A1 (en) 2007-12-20 2008-12-19 Sm-protein based secretion engineering

Publications (1)

Publication Number Publication Date
NZ586037A true NZ586037A (en) 2012-08-31

Family

ID=40344722

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ586037A NZ586037A (en) 2007-12-20 2008-12-19 Sm-protein based secretion engineering

Country Status (14)

Country Link
US (1) US20090247609A1 (enExample)
EP (1) EP2225389A1 (enExample)
JP (1) JP2011505850A (enExample)
KR (1) KR20100099190A (enExample)
CN (1) CN101903529A (enExample)
AR (1) AR069958A1 (enExample)
AU (1) AU2008340652A1 (enExample)
BR (1) BRPI0821389A2 (enExample)
CA (1) CA2709645A1 (enExample)
EA (1) EA201000945A1 (enExample)
IL (1) IL205239A0 (enExample)
NZ (1) NZ586037A (enExample)
TW (1) TW200932907A (enExample)
WO (1) WO2009080299A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012107634A (ru) 2009-09-18 2013-10-27 Селексис С.А. Способы и продукты для увеличенной экспрессии и процессинга трансгена
TW201823460A (zh) * 2012-05-29 2018-07-01 美商再生元醫藥公司 生產細胞株增強子
HUE043103T2 (hu) 2013-02-01 2019-08-28 Selexis Sa Fokozott transzgén expresszió és processzálás
AU2015367329B2 (en) 2014-12-19 2021-02-18 Merz Pharma Gmbh & Co. Kgaa Means and methods for the determination of the biological activity of BoNT/E in cells
CN106554973B (zh) * 2015-09-30 2020-05-22 北京吉尚立德生物科技有限公司 一种cho细胞分泌能力评价系统
JP7778377B2 (ja) * 2020-01-20 2025-12-02 イーブイ、セル、バイオテック、（コアンチョウ）、カンパニー、リミテッド 小胞及びその使用
WO2023155881A1 (en) * 2022-02-18 2023-08-24 Tsinghua University Methods for regulating secretion via migrasomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI924494A0 (fi) * 1992-10-06 1992-10-06 Valtion Teknillinen Oekad produktion av avsoendrarde proteiner i eukaryotiska rekombinantceller
EP1003889A1 (en) * 1997-08-05 2000-05-31 Chiron Corporation NOVEL $i(PICHIA PASTORIS) GENE SEQUENCES AND METHODS FOR THEIR USE
AU2002952550A0 (en) * 2002-11-08 2002-11-21 The University Of Queensland Modulating TNFalpha Secretion

Also Published As

Publication number Publication date
BRPI0821389A2 (pt) 2015-06-16
AR069958A1 (es) 2010-03-03
EA201000945A1 (ru) 2011-02-28
CN101903529A (zh) 2010-12-01
CA2709645A1 (en) 2009-07-02
TW200932907A (en) 2009-08-01
WO2009080299A8 (en) 2010-04-15
JP2011505850A (ja) 2011-03-03
US20090247609A1 (en) 2009-10-01
AU2008340652A1 (en) 2009-07-02
EP2225389A1 (en) 2010-09-08
IL205239A0 (en) 2010-11-30
WO2009080299A1 (en) 2009-07-02
KR20100099190A (ko) 2010-09-10

Similar Documents

Publication Publication Date Title
NZ586037A (en) Sm-protein based secretion engineering
CY1110734T1 (el) Μεθοδος παραγωγης μονιμων ανθρωπινων κυτταρικων σειρων
DK2274419T3 (da) Fremgangsmåder til fremstilling af hårmikrofollikler og de novopapiller og anvendelse heraf til in vitro-test og in vivo-implantationer
MX2009002524A (es) Incorporacion especifica de sitio de aminoacidos no naturales por celulas de vertebrados.
WO2007001264A3 (en) Method of making recombinant human antibodies for use in biosensor technology
WO2010042654A3 (en) Recombinant nell protein production
WO2009120762A3 (en) Human cardiovascular progenitor cells
SG162834A1 (en) Refolding of recombinant proteins
MY159971A (en) Multipotent/pluripotent cells and methods
MX343814B (es) Inmunomodulación usando celulas madre de la placenta.
EP4477668A3 (en) Heterodimeric antibody fc-containing proteins and methods for production thereof
EP4245766A3 (en) Prevention of disulfide bond reduction during recombinant production of polypeptides
WO2008114673A1 (ja) ポリペプチドの製造方法
WO2010082804A3 (en) Method for producing physiologically active protein or peptide using immunoglobulin fragment
WO2008065200A8 (en) Dnase expression in recombinant host cells
MX2010001319A (es) Metodo para producir proteinas heterogeneas.
BRPI0819649A2 (pt) método, organismo geneticamente modificado, e, célula de levedura recinbinante
NO331271B1 (no) Fusjonsprotein for sekresjon av et protein av interesse til supernatanten til en bakteriekultur, fremgangsmate, plasmid og vertscelle for fremstilling
EP1969127B8 (en) Method of producing biologically active vitamin k dependent proteins by recombinant methods
WO2007130543A3 (en) Method for producing stable mammalian cell lines producing high levels of recombinant proteins
UA99700C2 (ru) Способ приготовления иммортализированной человеческой клеточной линии
EP2189529A4 (en) RECOMBINANT MAMMALIAN CELLS, PROCESS FOR PRODUCING RECOMBINANT MAMMALIAN CELLS, AND METHOD FOR PRODUCING TARGET PROTEIN
ATE468398T1 (de) Herstellungsverfahren zur produktion aktiver und löslicher proteine in prokaryonten und polycistronische vektoren dafür
WO2011005554A3 (en) Recombinant ethanologenic bacteria
WO2007088051A3 (en) Modulation of mdl-1 activity for treatment of inflammatory disease

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 19 DEC 2015 BY SPRUSON + FERGUSON

Effective date: 20130225

LAPS Patent lapsed